Close

Analyst Ratings for Corcept Therapeutics (CORT) [Buys]

CORT Rating Summary

CORT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CORT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $35.50 (+42.1%) * Over Last 12-Mos
Rating Score: 5.3 / 10   Percentile Rank: 55%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/27/2022 Jefferies Dennis Ding New Coverage Buy
(N/A)
35.00
(N/A)
26.81
(24.98)
-6.83% Details
6/27/2022 Canaccord Genuity Edward Nash New Coverage Buy
(N/A)
34.00
(N/A)
23.80
(24.98)
4.96% Details
Like CORT Ratings? Also take a look at MFIN, AGFY, RBB, CDNA

CORT Ratings News